FeS/CeO2/Curcumin heterojunction for infectious arthritis therapy through synergistic sonodynamic-H2S and ultrasound modulated nanozyme as well as osteogenesis
摘要
The treatment of infectious arthritis faces multiple challenges, including the exacerbation of traditional antibiotic resistance and the difficulty of regulating the tissue microenvironment. In this study, the FeS/CeO2/Cur (curcumin) heterostructure was constructed through interface engineering, and an ultrasonic (US) responsive nanotherapeutic platform was proposed, which combined sonodynamic-H2S antibacterial action with US modulated nanozyme activity. FeS/CeO2/Cur integrated the intrinsic redox properties of Ce3+/Ce4+ with the piezoelectric catalytic effect. Under US irradiation, FeS/CeO2/Cur nanozyme exhibited an interface-enhanced piezoelectric effect. It generated ·O2− and ·1O2 radicals through piezoelectric catalytic activity, while achieving the US-responsive release of H2S. The Ce3+/Ce4+ dynamic equilibrium system triggered shows US modulated antioxidant properties, which can scavenge pathogenic ROS by Ce3+/Ce4+ redox cycling during the interface. FeS/CeO2/Cur's sonodynamic antibacterial activity revealed that it achieved broad-spectrum sterilization by disrupting bacterial ATP metabolism and regulating related genes, including narG, purM, and narJ. The in vivo bacterial arthritis model also confirmed that FeS/CeO2/Cur can eliminate bacteria rapidly and promote osteogenic differentiation, providing an effective treatment strategy for infectious arthritis.
Graphical abstract